Welcome to the Rubinstein-Taybi Syndrome Foundation Community

Tied Together. Advancing Research. Empowering the Rubinstein-Taybi Community.

What is Rubinstein-Taybi Syndrome?

Rubinstein-Taybi Syndrome (RTS) is a rare genetic neurodevelopmental disorder that can affect every body system. Occuring in approximately 1 out of every 150,000 live births, RTS is caused by spontaneous mutations in the CREBBP or EP300 genes, with a small number of cases inherited from parents. RTS does not discriminate and has been observed across ethnicities, localities, and genders. The condition is characterized by intellectual disability, along with clinical and behavioral phenotypes. 


Currently, there are no disease-treating therapies available to the RTS community; and symptom-treating therapies are limited. Our goal is to change that.

Our Shared Mission

Rare diseases require collective action. By bringing together patients,
caregivers, clinicians, researchers, and industry partners, we aim to:

For Patients &
Caregivers:

If you have been newly diagnosed with Rubinstein-Taybi Syndrome (RTS), or caring for someone who is welcome. You may be navigating unfamiliar medical language, difficult decisions, and emotional uncertainty. We are here to help you find clarity, connection, and support. 

Receiving a rare disease diagnosis can feel overwhelming and isolating, and you may have more questions than answers right now. We want you to know one important thing from the start: you are not alone.

This website was created for people just like you. We recognize that every journey is unique, but many of the uncertainties you may be feeling are shared by others who have walked this path before. 

And if you are a community member, family member, or caregiver who has been walking this path for sometime, please consider this website the newest asset in your care team’s portfolio. Together, we can raise awareness, invest in research, and pursue potentially life changing therapies. 

Our goal at Rubinstein-Taybi Syndrome Foundation is to tie together the stakeholders in this mission, and that starts with the most important stakeholders: our community.

For Researchers and Industry Leaders:

Your partnership matters.

Progress in rare disease research depends on collaboration, shared knowledge, and meaningful engagement with the patient community. This platform serves as a bridge between those living with Rubinstein-Taybi Syndrome and those working to understand and treat it.

Our research strategy focuses on building the scientific foundation needed to move from understanding Rubinstein-Taybi Syndrome to developing effective treatments.

Through the BRIDGE Campaign, we are connecting families, clinicians, and scientists to accelerate research progress in RTS. Our goal is to raise $2 million to establish the infrastructure needed to support discovery, collaboration, and the development of future therapies.

Together, we can transform patient experience into scientific insight and scientific insight into meaningful treatments.

Researchers and industry partners are invited to connect with us to explore collaborative opportunities.

Contact: Rcortese@rubinsteintaybi.org

Making complex terminology simple, accessible, and empowering.

Explore our glossary of commonly used genetics, research, and Rubinstein-Taybi syndrome terms.
Designed to help individuals, families, and caregivers learn with confidence.

Donate / Fund Raising Roadmap

Join RTS Foundation’s Circle of Hope campaign and help change what an RTS diagnosis means for individuals and families.